Abstract:ObjectivesProstate cancer (PCa) diagnosis still relies on 12-core systematic biopsy (SBx). More recently, pre-biopsy multiparametric MRI has been introduced in the guidelines as a valuable imaging tool for the detection of significant PCa. However, poor reproducibility and specificity, along with its high cost and limited availability, evidence the need for cost-effective, widespread imaging alternatives. 3D contrast-enhanced ultrasound (CEUS) has shown promise for PCa localization by extraction of quantitative perfusion and dispersion features associated with cancer angiogenesis. Tissue stiffness is an additional PCa biomarker that can be quantified by ultrasound shear-wave elastography (SWE). In this study, the diagnostic potential of multiparametric ultrasound imaging, combining 3D CEUS and SWE features, was evaluated for PCa localization by comparison with the corresponding SBx outcome.MaterialsAfter signing an informed consent, 54 biopsy-naïve patients underwent a 3D CEUS recording using a LOGIQ E9 scanner (GE HealthCare, USA) and a multi-plane (probe sweep) 2D SWE scan using an Aixplorer scanner (SuperSonic Imagine, France) at the Second Affiliated Hospital of Zhejiang University (China). All patients received SBx. Multiple 3D perfusion and dispersion feature maps were extracted from the 3D CEUS acquisitions and further complemented with 3D maps of tissue stiffness, reconstructed based on the multi-plane 2D SWE acquisitions. Subsequently, all the 3D maps were subdivided in 12 regions corresponding to the SBx locations. Gradient Boosting (GB) classification was then implemented together with sequential floating forward feature selection for prediction of the biopsy outcome. The classification accuracy was assessed by a k-fold cross-validation procedure.ResultsOf the 54 patients, 20 had SBx-proven significant PCa. Prediction of biopsy outcome using only CEUS features produced an area under the receiver-operating-characteristic curve (AUC) of 0.81, while using the SWE elasticity alone produced an AUC of 0.66. Their combination yielded an improved AUC of 0.85.ConclusionsThe proposed 3D multiparametric ultrasound imaging approach yields accurate PCa classification results, showing promise for cost-effective PCa localization by multiparametric ultrasound imaging. A multicenter trial has recently started to validate and optimize the classification performance in a larger patient cohort.

Comparison of Contrast-Enhanced Ultrasound Targeted Biopsy Versus Standard Systematic Biopsy for Clinically Significant Prostate Cancer Detection: Results of a Prospective Cohort Study with 1024 Patients

Transrectal contrast enhanced ultrasound targeted biopsy for detection prostate cancer:comparison with systematic biopsy

Significance of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer

Contrast-enhanced Ultrasound Targeted Biopsy for the Clinically Significant Prostate Cancer Detection

3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

3-D Multi-parametric Contrast-Enhanced Ultrasound for the Prediction of Prostate Cancer.

Contrast-enhanced Ultrasound Targeted Versus Conventional Ultrasound Guided Systematic Prostate Biopsy for the Accurate Diagnosis of Prostate Cancer: A Meta-Analysis

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

Diagnostic Value of Different Systematic Prostate Biopsy Methods in the Detection of Prostate Cancer with Ultrasonographic Hypoechoic Lesions - A Comparative Study

Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions.

Diagnostic Accuracy of Qualitative and Quantitative Magnetic Resonance Imaging-Guided Contrast-Enhanced Ultrasound (Mri-Guided CEUS) for the Detection of Prostate Cancer: a Prospective and Multicenter Study

A Prospective Multicenter Study on the Additive Value of Contrast-Enhanced Ultrasound for Biopsy Decision of Ultrasound BI-RADS 4 Breast Lesions

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naive Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis

Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: Comparison with conventional ultrasonography

Comparative diagnostic accuracy of multiparametric magnetic resonance imaging-ultrasound fusion-guided biopsy versus systematic biopsy for clinically significant prostate cancer

Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound.

Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer

A Comparative Study of Transrectal Contrast-Enhanced Ultrasound Assisted Prostate Biopsy and System-Ic Prostate Biopsy

Prostate Cancer: A Comparison of the Diagnostic Performance of Transrectal Ultrasound Versus Contrast Enhanced Transrectal Ultrasound in Different Clinical Characteristics

Comparison Of Contrast-Enhanced Ultrasound And Conventional Ultrasound For Guiding Peripheral Pulmonary Biopsies